NEW YORK — The emergence of a worrisome coronavirus variant is benefiting shares of vaccine makers Moderna Inc, BioNTech and Pfizer as investors search for winning bets in markets roiled by uncertainty in recent days. Read More
As Omicron Plays Havoc With Markets, Shares of Vaccine Makers Surge
